Medical Staff News
News
Mental Health Act Resources
The resource lists all the education and practice support tools that are available to assist you in working with persons who are being involuntarily treated for their mental health issues under the MHA.
Update to COVID-19 testing guidance and PCR tests for health care workers
Provincial COVID-19 testing guidance has been updated.
Upcoming Wellness Webinars
Register in the Learning Hub for any of these free upcoming Wellness webinars.
Smoky Skies Bulletin and Air Quality Advisories
Environment and Climate Change Canada says all of Vancouver Island and the Southern Gulf Islands will be impacted over the next 24 to 48 hours, if they aren’t already, by wildfire smoke.
BCCDC COVID-19 Long Term Care, Assisted Living & Other Residential Outbreak Report
A weekly update for Long-Term Care, Assisted Living & Other Residential Living Facilities.
Geographic Distribution of COVID-19 by Local Health Area of Case Residence
Epi-Week 40 Cases October 2 to 8, 2022.
COVID-19 Situation Report
This BCCDC report provides weekly data and refers to pandemic phases defined by population-level changes.
Ethics Lunch & Learn October 19th 2022!
Please save the zoom details in your calendar and join the Island Health Ethics team in an engaging clinical ethics discussion at the October Ethics Lunch & Learn!
SSC-Island Health PQI & SQI Committee Members Select Physician Co-Chair
The SSC-Island Health PQI & SQI Committee is lucky to have Dr. Alex Hoechsmann on board; Dr. Hoechsmann brings a lot of QI knowledge and experience, and above all a positive energy to the committee!
Update to Communicable Disease Control Manual, Chapter 2: Immunization, Part 4 – Biological Products & Appendix E – Management of Biologicals
BCCDC Guidance Manual updated for COVID-19 Vaccine Eligibility includes updates such as: COVID-19 Vaccine Eligibility - Pfizer Bivalent COVID-19 vaccine has been added to the fall booster dose recommendations and is approved for those 12 years of age and older, a footnote has been added to indicate the Moderna Bivalent vaccine is the preferred product for those 12 years of age and older who are moderately to severely immunosuppressed. (Target audience: Holders of Communicable Disease Control Manuals).